PANOXYL CLARIFYING EXFOLIANT- salicylic acid liquid 
Crown Laboratories, Inc.

----------

PanOxyl Clarifying Exfoliant

Active ingredient

Salicylic Acid 2%

Purpose

Acne Medication

Use

Warnings

For external use only

When using this product

  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Other information

Inactive ingredients

Betaine, Butylene Glycol, Chamomilla Recutita (Matricaria) Flower Extract, Glycerin, Hydroxyacetophenone, Pentylene Glycol, Phenoxyethanol, Potassium Sorbate, Propanediol, Purified Water, Sodium Benzoate, Sodium Citrate Dihydrate, Sorbic Acid, Spirulina Platensis (Blue Algae) Extract

Questions or comments?

call 1-833-279-6522

Panoxyl Clarifying Exfoliant Bottle

new

NDC 0316-0296-04

DERMATOLOGIST RECOMMENDED

PanOxyl®

Clarifying Exfoliant

2% Salicylic Acid

4 fl oz (118 mL)

PanOxyl Exfoliant

PANOXYL CLARIFYING EXFOLIANT 
salicylic acid liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0316-0296
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID2 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
BETAINE (UNII: 3SCV180C9W)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
MATRICARIA CHAMOMILLA FLOWERING TOP (UNII: 3VNC7T6Z02)  
GLYCERIN (UNII: PDC6A3C0OX)  
HYDROXYACETOPHENONE (UNII: G1L3HT4CMH)  
PENTYLENE GLYCOL (UNII: 50C1307PZG)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
PROPANEDIOL (UNII: 5965N8W85T)  
WATER (UNII: 059QF0KO0R)  
SODIUM BENZOATE (UNII: OJ245FE5EU)  
SORBIC ACID (UNII: X045WJ989B)  
TRISODIUM CITRATE DIHYDRATE (UNII: B22547B95K)  
SPIRULINA PLATENSIS (UNII: 9L3TIH1UUE)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0316-0296-04118 mL in 1 BOTTLE; Type 0: Not a Combination Product06/02/2023
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00606/01/2023
Labeler - Crown Laboratories, Inc. (079035945)
Establishment
NameAddressID/FEIBusiness Operations
Crown Laboratories, Inc.079035945manufacture(0316-0296)

Revised: 10/2023
Document Id: 08a44d1a-b01b-80bc-e063-6294a90af2bd
Set id: faa6576c-2af2-d86b-e053-6294a90ada2d
Version: 2
Effective Time: 20231026
 
Crown Laboratories, Inc.